Get started
Cabaletta Bio, Inc.Cabaletta Bio, Inc.Cabaletta Bio, Inc.

Cabaletta Bio, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

CABA chart

Key stats

Market capitalization
‪821.55 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.66USD
Net income
‪−67.68 M‬USD
Revenue
—
Shares float
‪34.77 M‬
Beta (1Y)
2.40

About Cabaletta Bio, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Steven Nichtberger
Website
cabalettabio.com
Headquarters
Philadelphia
Employees (FY)
103
Founded
2017
ISIN
US12674W1099
FIGI
BBG00MJ3BKW2
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CABA is 16.18 USD — it has decreased by 4.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cabaletta Bio, Inc. stocks are traded under the ticker CABA.
Cabaletta Bio, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Cabaletta Bio, Inc. has a max estimate of 50.00 USD and a min estimate of 25.00 USD.
CABA earnings for the last quarter are −0.37 USD whereas the estimation was −0.40 USD which accounts for 8.29% surprise. Estimated earnings for the next quarter are −0.39 USD. See more details about Cabaletta Bio, Inc. earnings.
Yes, you can track Cabaletta Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, CABA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cabaletta Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CABA reached its all-time high on Feb 8, 2024 with the price of 26.35 USD, and its all-time low was 0.59 USD and was reached on Sep 23, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 103.00 employees. See our rating of the largest employees — is Cabaletta Bio, Inc. on this list?